Schedule 13G ownership disclosure

SENSEI BIOTHERAPEUTICS INC

Security class unavailable · CUSIP: 81728A108

Event date: 2023-07-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
0.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000897069-23-001093
Form type
SC 13G/A
Filer
Cambrian BioPharma Inc
CIK
CIK 1797409
Filed
Aug 04, 2023
Reporting period
Jul 31, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub